KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Progyny (PGNY) Liabilities and Shareholders Equity (2018 - 2025)

Progyny (PGNY) has disclosed Liabilities and Shareholders Equity for 8 consecutive years, with $742.4 million as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity rose 22.29% to $742.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.0 billion through Dec 2025, up 17.73% year-over-year, with the annual reading at $742.4 million for FY2025, 22.29% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $742.4 million at Progyny, down from $795.2 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $795.2 million in Q3 2025, with the low at $294.6 million in Q1 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $582.5 million, with a median of $628.4 million recorded in 2023.
  • The sharpest move saw Liabilities and Shareholders Equity surged 66.63% in 2021, then decreased 19.76% in 2024.
  • Over 5 years, Liabilities and Shareholders Equity stood at $358.1 million in 2021, then soared by 51.64% to $543.0 million in 2022, then skyrocketed by 39.34% to $756.6 million in 2023, then fell by 19.76% to $607.1 million in 2024, then rose by 22.29% to $742.4 million in 2025.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods came in at $742.4 million, $795.2 million, and $760.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.